The health risk associated with tobacco use in people with severe mental illness is much higher than the general population. Among them, patients with schizophrenia are the population with perhaps the highest risk for nicotine addition. Current conceptualizations of the possible etiologies of the severe schizophrenia-smoking comorbidity include self-medication for neurocognition deficits, overcoming antipsychotic medication side effects, and shared nicotinic molecular pathways. However, the underlying brain circuitry for the comorbidity is unknown. Identifying brain comorbidity circuitry is critical for developing valid biomarkers for clinical therapeutic development, individualizing treatment selection and outcome prediction. Recent data suggest that the cingulate-ventral striatum circuit appears to be one of the key pathways associated with nicotine addiction. These same areas are also among the regions most commonly implicated in schizophrenia, and additional preliminary studies suggest that the same circuit is impaired in schizophrenia. Therefore, we hypothesize that abnormal cingulate-ventral striatum circuit is a key path for schizophrenia/nicotine addiction comorbidity. We propose to test the hypotheses that the cingulate-ventral striatum circuit is abnormal in nicotine addiction and in schizophrenia, and that schizophrenia pathology disrupts this circuit and predisposes patients to more severe nicotine addiction, leading to the severe nicotine addiction/schizophrenia comorbidity. We will also examine the clinical validities of the circuit in prediction of long-term smoking behavioral change, in genetics, and in its relationships to putative addiction mechanisms. Identifying the key brain circuits associated with smoking in this high risk population will provide concrete biomarkers for new therapeutic development, and ultimately reducing the smoking related health burden in schizophrenia patients. In addition, as public health efforts have reduced smoking, those who still smoke in the population may be more dependent and more treatment-resistant. An effort targeting the population most addicted to smoking may also yield novel perspectives to treat nicotine addiction in the general population.
People with schizophrenia have high rate of smoking, which is often resistant to available treatment. This study aims to identify the brain circuit responsible for the smoking comorbidity in these patients, which should lead to better treatment strategy for reducing smoking and smoking related health burden in schizophrenia patients and perhaps also in other treatment-resistant smokers in the general population.
|Rowland, Laura M; Summerfelt, Ann; Wijtenburg, S Andrea et al. (2016) Frontal Glutamate and Î³-Aminobutyric Acid Levels and Their Associations With Mismatch Negativity and Digit Sequencing Task Performance in Schizophrenia. JAMA Psychiatry 73:166-74|
|Wang, Qi; Chen, Rong; JaJa, Joseph et al. (2016) Connectivity-Based Brain Parcellation: A Connectivity-Based Atlas for Schizophrenia Research. Neuroinformatics 14:83-97|
|Chiappelli, Joshua; Shi, Qiaoyun; Kodi, Priyadurga et al. (2016) Disrupted glucocorticoid--Immune interactions during stress response in schizophrenia. Psychoneuroendocrinology 63:86-93|
|Kochunov, Peter; Ganjgahi, Habib; Winkler, Anderson et al. (2016) Heterochronicity of white matter development and aging explains regional patient control differences in schizophrenia. Hum Brain Mapp 37:4673-4688|
|Du, Xiaoming; Kochunov, Peter; Summerfelt, Ann et al. (2016) The role of white matter microstructure in inhibitory deficits in patients with schizophrenia. Brain Stimul :|
|Rowland, L M; Krause, B W; Wijtenburg, S A et al. (2016) Medial frontal GABA is lower in older schizophrenia: a MEGA-PRESS with macromolecule suppression study. Mol Psychiatry 21:198-204|
|Kochunov, Peter; Thompson, Paul M; Winkler, Anderson et al. (2016) The common genetic influence over processing speed and white matter microstructure: Evidence from the Old Order Amish and Human Connectome Projects. Neuroimage 125:189-97|
|Kuehner, Ryan M; Kochunov, Peter; Nugent, Katie L et al. (2016) Cognitive profiles and heritability estimates in the Old Order Amish. Psychiatr Genet 26:178-83|
|Kochunov, Peter; Fu, Mao; Nugent, Katie et al. (2016) Heritability of complex white matter diffusion traits assessed in a population isolate. Hum Brain Mapp 37:525-35|
|Chiappelli, Joshua; Postolache, Teodor T; Kochunov, Peter et al. (2016) Tryptophan Metabolism and White Matter Integrity in Schizophrenia. Neuropsychopharmacology 41:2587-95|
Showing the most recent 10 out of 55 publications